Evolent Health (EVH) Cash from Operations (2015 - 2026)

Evolent Health's Cash from Operations history runs 12 years deep, the most recent figure standing at 984000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 121.56% year-over-year to 984000.0 in Q1 2026; TTM through Mar 2026 was 33294000.0, a 80.74% increase from a year earlier, with the FY2025 full-year figure at 38843000.0, up 107.0% from the prior year.
• Cash from Operations eased to 984000.0 in Q1 2026 per EVH's latest filing, from 48800000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 89381000.0 in Q4 2023 and bottomed at 57442000.0 in Q1 2022.
• The 5-year median for Cash from Operations is 4909000.0 (2024), against an average of 11038411.76.
• Across the five-year window, Cash from Operations jumped 3174.77% in 2024 and slumped 241.64% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 35695000.0 in 2022, then soared by 150.4% to 89381000.0 in 2023, then slumped by 129.35% to 26231000.0 in 2024, then surged by 286.04% to 48800000.0 in 2025, then sank by 102.02% to 984000.0 in 2026.
• Per Business Quant, the three latest EVH Cash from Operations figures stand at 984000.0 (Q1 2026), 48800000.0 (Q4 2025), and 15812000.0 (Q3 2025).